Efficacy of Ivermectin in Adult Patients With Early Stages of COVID-19 (EPIC Trial)

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020

This article is included in 1 Systematic review Systematic reviews (1 reference)

This article is part of the following publication threads:
Loading references information
Double blind, placebo controlled, randomized clinical trial to evaluate the efficacy of ivermectin in preventing progression of disease in adult patients with early stages of COVID-19
Epistemonikos ID: 12377a92b7bcdf5d6042209ae05d418d2f17b3c0
First added on: May 29, 2020